Andrew Mitchell - Senior Director, Business Development
Joined BioVectra in 2017 as the European Business Development Manager
Promoted to BioVectra’s Senior Director, Business Development in 2020
30 years of experience in the global pharmaceutical & fine chemical area
Experience in synthesis, and fermentation covering both CDMO and Generics industries
Worked with a number of organizations, with various specialized capabilities such as large scale chromatography, energetic chemistry, biocatalysis, high containment & microbial fermentation of small molecules
Andrea Dawson - Senior Director, Project Management
Bachelor of Chemical Engineering from Dalhousie University.
More than 20 years in progressive leadership roles within the Manufacturing environment.
Joined BIOVECTRA in March 2010 in the role of Manufacturing Manager (API).
Promoted to Director, Contract Manufacturing in 2014.
Seconded to a two year term position of Director, Capital Projects in 2018.
Appointed to a Project Director position for a 6-month term in 2019.
Promoted to BIOVECTRA’s Senior Director, Project Management in 2020.
Andrea McCormick - Director, Manufacturing Partnerships, Biologics
B.Sc. in chemistry from University of New Brunswick 1995
M.Sc. in Analytical Chemistry from the University of British Columbia 1998
Certificate in Project Management from University of California Berkeley 2004
Joined BIOVECTRA in 2017 as a Project Manager
Prior to joining BIOVECTRA was Manager, Technology Commercialization, Life and Health Sciences at Dalhousie University, Project Manager with Genentech, and an Analytical Chemist at several start-up companies including GeneSoft and AnorMed
Joined BIOVECTRA in 2017 as a Project Manager
Jon S. Gingrich – Key Account Manager – Biologics
Bachelors of Science – Chemistry – CSUC 1986
12 years experience in the Contract Development and Manufacturing of Biologics industry
Subject matter expert in Single Use Bioreactor technology
Joined BioVectra’s Business Development group in the summer of 2020
Kristina Borštnik - Director, Business Development
B.A. degree in Chemistry and Biology from St. Mary’s College of Maryland
Ph.D. degree in Organic Chemistry from Johns Hopkins University
13 years of experience in supporting CMO programs from early phase through commercial manufacture
Prior to joining BIOVECTRA, worked at AMRI in a variety of roles including process chemistry, project management, and sales
Joined BIOVECTRA in 2020 as Director, Business Development for the East Coast
David Young - Manager, Sales
B.Sc. and M.Sc. in Biochemistry from Queen’s University (1986)
Worked in R&D, process development, and manufacturing at Cangene Corporation from 1986-1998
Promoted to Sales Manager, Contract Manufacturing at Cangene in 1998 – 2009
Transitioned to National Sales Manager in Canada for Cangene’s WinRho and HepaGam B products in 2009-2012
Established consulting business in the pharma/biotech industry focused on drug development, contract manufacturing, healthcare investment banking and business development in 2012
Joined BIOVECTRA as Product Manager for the Bioprocessing Reagents Group in 2016
Amanda Sauer - Project Operations Manager
B.Sc. Degree in Chemistry from University of Prince Edward Island (2001)
Ph.D. Degree in Chemistry from University of British Columbia (2006)
Joined BIOVECTRA in 2006 as a research chemist and in 2007 assumed the role of Project Manager
Promoted to Manager, Client Services & Project Management in 2015
Promoted to Project Operations Manager in 2020
Sarah Collins - Manager, Commercial Operations
Bachelor of Science from Dalhousie in 2006 Major in Neuroscience
Masters of Business Administration in 2009 with a concentration in International Business
Eight years of experience in project management, business development and commercialization support focusing largely within the bioscience, agriculture, value added agri-food, and energy sectors
Joined BioVectra as Project Manager in 2015
Promoted to Business Analyst in 2017
Promoted to Manager, Commercial Operations in 2020
Alex Gatien – Project Manager
5 years of experience in early stage R&D and pharmaceutical projects.
Experience in synthesis, catalysis, and process development in CRO and CDMO environments.
Worked with a variety of start-up and multinational pharmaceutical companies to drive product-development processes.
Joined BIOVECTRA in 2020 as Project Manager.
Alex Hendry - Project Manager
B.Sc. Degree from the University of New Brunswick in 2008, majoring in Medicinal Chemistry with a minor in Marketing
Previously worked as a Territory Manager/Account Representative for a beverage distribution company in Atlantic Canada, and has experience in business to business as well as retail sales
Joined BioVectra in 2009 as Distribution Sales Representative
Promoted to Business Development Representative in 2014
Promoted to Project Manager in 2018
Maryam Khodadadi – Project Manager
Ph.D. in Food Science and Agricultural Chemistry from McGill University (2012).
Continued at McGill for the completion of her Postdoc studies. Her research work was focused on the biosynthesis of products such as prebiotics, and β-Glucans through the valorization of industrial waste streams.
Over 12 years of experience in the innovation and biosynthesis of nutraceuticals and bioactive molecules, microalgal fermentation, process scale-up and analytical chemistry.
Joined BIOVECTRA’s Project Management team in March 2020.
Mitch Malboeuf – Project Manager
C.E.T. in Mechanical Engineering Technology, Ontario, Canada (2011)
Has 10 years of experience in the Aerospace, Food & Beverage (Brewery) and Pharmaceutical industries as Manufacturing Engineer Planner and Project Manager
Joined BIOVECTRA in 2020 as Project Manager
Jimmy Rowley – Project Manager
MSc in Chemistry from UPEI.
Has previous experience in sales and has experience running small businesses.
Previous worked with companies in developing projects from Pilot scale to commercial scale.
Joined BioVectra in 2014 and has held roles in Manufacturing and Process Transfer/Scale-Up as well as assignments with Fermentation and R&D.
Has worked on various projects including High Potent, microbial ferments, and a number of Synthetic processes.
Promoted to Project Manager in 2019.
Oliver Technow - Chief Executive Officer
Industry Master Degree from Frankfurt Chamber of Commerce, Frankfurt Germany.
More than 20 years of global pharmaceutical industry experience.
Held numerous leadership positions in commercial development, marketing and brand management, and lifecycle management and has extensive product launch and market access expertise in Europe and North America.
In 1997, joined Eisai GmbH in Frankfurt, Germany and in 2002, was appointed Director, CNS Business Unit; in 2006, was appointed Vice President, Head of Global Marketing for Eisai Inc. in Woodcliff Lake, NJ; in 2011, was appointed Vice President, Established Products Business Unit; in 2013, was appointed President & General Manager for Eisai Limited in Mississauga, ON.
Appointed President of BIOVECTRA Inc., December 10, 2015.
Board Director for BIOTECanada
Member of the Steering Council of Innovative Medicines Canada (IMC)
In 2017, appointed to the Government of Canada’s Health/Bio-sciences Strategic Economic Table
In November 2019, promoted to Chief Executive Officer at BIOVECTRA
In June 2020, named new Chair of PEI BioAlliance Board of Directors